At-home palliative sedation for end-of-life cancer patients

Palliative Medicine

Volumn 24, Issue 5, 2010, Pages 486-492

  Alonso Babarro, Alberto ^a   Varela Cerdeira, Maria ^b   Torres Vigil, Isabel ^c   Rodríguez Barrientos, Ricardo ^d   Bruera, Eduardo ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Investigation Unit   (Spain)

^c UNIVERSITY OF TEXAS   (United States)

^d Técnico Unidad Docente   (Spain)

Author keywords

end of life care; home care; midazolam; palliative care; Palliative sedation; terminal care

Indexed keywords

LEVOMEPROMAZINE; MIDAZOLAM; PHENOBARBITAL;

ARTICLE; CANCER PATIENT; CLINICAL DECISION MAKING; CONTINUOUS INFUSION; DELIRIUM; DRUG SAFETY; DYING; DYSPNEA; FAMILY COPING; HOSPICE CARE; HUMAN; INCIDENCE; PALLIATIVE THERAPY; PATIENT SAFETY; RETROSPECTIVE STUDY; SEDATION; TERMINAL CARE; TREATMENT RESPONSE;

AGED; CHECKLIST; CONSCIOUS SEDATION; FEMALE; HOME CARE SERVICES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SPAIN; TERMINALLY ILL;

EID: 77953972224     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216309359996     Document Type: Article

References (26)

1. De Graeff A., Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007 ; 10: 67-85.
2. Morita T., Bito S., Kurihara Y., Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 2005 ; 8: 716-729.
3. Chater S., Viola R., Paterson J., Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998 ; 12: 255-269.
4. Cowan JD, Walsh D. Terminal sedation in palliative medicine - definition and review of the literature. Support Care Cancer 2001 ; 9: 403-407.
5. Levy MH, Cohen SD Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol 2005 ; 32: 237-246.
6. Claessens P., Menten J., Schotsmans P., Broeckaert B. Palliative sedation: a review of the research literature. J Pain Symptom Manage 2008 ; 36: 310-333.
7. Ventafridda V., Ripamonti C., De Conno F., Tamburini M., Cassileth BR Symptom prevalence and control during cancer patients last days of life. J Palliate Care 1990 ; 6: 7-11.
8. Porta Sales J., Ylla-Catalá Bore E., Estíbalez Gil A., et al. Estudio multicéntrico catalano-balear sobre la sedaci3n terminal en cuidados paliativos. Med Pal (Madrid) 1999 ; 6: 153-158.
9. Peruselli C., Di Giulio P., Toscani F., et al. Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med 1999 ; 13: 233-241.
10. Bulli F., Miccinesi G., Biancalani E., et al. Continuous deep sedation in home palliative care units: case studies in the Florence area in 2000 and in 2003-2004. Minerva Anestesiol 2007 ; 73: 291-298.
11. Porzio G., Aielli F., Verna L., Micolucci G., Aloisi P., Ficorella C. Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study. Support Care Cancer 2010 ; in press.
12. Rosengarten OS, Lamed Y., Zisling T., Feigin A., Jacobs JM Palliative sedation at home. J Palliat Care 2009 ; 25: 5-11.
13. Rietjens J., van Delden J., Onwuteaka-Philipsen B., Buiting H., van der Maas P., van der Heide A. Continuous deep sedation for patients nearing death in the Netherlands: descriptive study. Br Med J 2008 ; 336: 810-813.
14. Porta-Sales J. Sedation and terminal care. Eur J Paliat Care 2001 ; 8: 97-100.
15. Cowan JD, Palmer TW Practical guide to palliative sedation. Curr Oncol Rep 2002 ; 4: 242-249.
16. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974 ; 2: 656-659.
17. Fainsinger RL, Waller A., Bercovici M., et al. A multi-centre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000 ; 14: 257-265.
18. Elsayem A., Curry Iii E., Boohene J., et al. Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer 2009 ; 17: 53-59.
19. Mercadante S., Intravaia G., Villari P., Ferrera P., David F., Casuccio A. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage 2009 ; 37: 771-779.
20. Rietjens JA, van Zuylen L., van Veluw H., van der Wijk L., van der Heide A., van der Rijt CC Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation. J Pain Symptom Manage 2008 ; 36: 228-234.
21. Kohara H., Ueoka H., Takeyama H., Murakami T., Morita T. Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med 2005 ; 8: 20-25. (Pubitemid 40144248)
22. Morita T., Inoue S., Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996 ; 12: 32-38.
23. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001 ; 21: 467-472.
24. Fainsinger RL, Núñez-Olarte JM, Demoissac DM The cultural differences in perceived value of disclosure and cognition: Spain and Canada. J Palliat Care 2003 ; 19: 43-48.
25. Centeno Cortés C., Núñez Olarte JM Studies about the communication of the diagnosis of cancer in Spain. Med Clin (Barc) 1998 ; 110: 744-750.
26. Chater S., Viola R., Paterson J., Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998 ; 12: 255-269.